Biotechnology | North America COVID-19: Increasing ConvictionMultiple Vaccine Candidates WillHave Pivotal Data Before YE20 While a pre-election result is possible, we see early-to-mid November as our base case for PhIII data. Pfizer/BioNTech and Moderna appear slightly ahead of AstraZeneca for US PhIII data, though we note many details on the PhIIIs have not been disclosed which could impact our projected…
Morgan Stanley Biotechnology Team: Year-End Vaccine Probable
A financial market resource for the every-day investor and trader.
-
Weekly State of the Market: Taper Tantrum Afoot?
Seth Golden, , Research Reports, 0
They say the trading hierarchy is 10% Technical analysis, 30% Risk Management and 60% Patience & Emotion management. If...
-
Bill Miller: Some Reflections on the Bull at 10
Seth Golden, , Research Reports, 0
1Q 2019 Market Letter The bull market that began in early March 2009 passed its 10th birthday last month,...
-
Amazon’s Acquisitions Create Adverse Reactions
Seth Golden, , Research Reports, 0
The reality is far more innocuous than the reaction sometimes. When Amazon (AMZN) announced its acquisition of Whole Foods...
-
Leuthold Group: The Job Market Just Rescinded A Recession Signal
Seth Golden, , Research Reports, 0
For those disappointed that February’s employment report won’t be released until March 10th, we have something to consider in...
-
Equity Markets Look For Balance Amidst Trade War And Reflation Fears
Seth Golden, , Research Reports, 0
This week is likely to prove a considerably important week as equity markets have gyrated back and forth throughout...
-
Alibaba (BABA): Rich Country, Strong Army
Seth Golden, , Research Reports, 0
The following Alibaba fundamental research reporting is delivered via the team at Fundstrat: Summary While political risk has significantly...
-
Weekly State of the Market: In The Face of A Bearish Backdrop, Bulls Reimmerge
Seth Golden, , Research Reports, 0
If we know that bad times are temporary and progress is undefeated, why is it so hard to stay...
-
The Leuthold Group: Putting The “Sahm Rule” To The Test
Seth Golden, , Research Reports, 0
In January, the “inventor” of the yield-curve indicator—Campbell Harvey of Duke University—suggested that the inversion of the 10Y/3M spread...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00